Clinical and Biological Aspects of the MONKEYPOX Disease (PoxVac22)
Monkey Pox
About this trial
This is an interventional basic science trial for Monkey Pox focused on measuring vaccination, infection, monkey pox virus, outbreak, immunization
Eligibility Criteria
Inclusion Criteria: Adult, eligible for MPXV vaccination according to HAS criteria or suspected of MPXV infection whose health status is compatible with a 45 ml single blood sample who have consented to participate in the study who are covered by a Social Health Insurance plan Exclusion Criteria: Person with MPXV vaccination without proof of vaccination. For persons presenting for MPXV vaccination: presence of a contraindication to vaccination other than a current infection. Pregnant and lactating women Person unable to give informed consent to participate
Sites / Locations
- Centre Médical de l'Institut PasteurRecruiting
Arms of the Study
Arm 1
Other
Individuals coming to CMIP for MONKEYPOX disease management
300 individuals eligible for MPXV vaccination and 30 individuals suspected of MPXV infection.